Idiopathic pulmonary fibrosis (IPF) is a fibrosing interstitial lung disease of unknown etiology.
Different types of cells are involved in fibrogenesis, which is persistently physical and …

Idiopathic pulmonary fibrosis (IPF) is a progressive lung disease that occurs due to
increased fibrosis of lung tissue in response to chronic injury of the epithelium. Therapeutic …

Idiopathic pulmonary fibrosis (IPF) is a chronic, progressive, irreversible, and highly fatal
disease. It is characterized by the increased activation of both fibroblast and myofibroblast …

Introduction: Interstitial lung diseases (ILDs) are a heterogeneous group of diffuse
parenchymal lung disorders characterized by the pathogenetic involvement of interstitium …

Idiopathic pulmonary fibrosis (IPF) affects an increasing number of people globally, yet
treatment options remain limited. At present, conventional treatments depending on drug …

Rationale: Idiopathic pulmonary fibrosis (IPF) is a lethal lung disease characterized by lung
epithelial cell injury, increased (myo) fibroblast activation, and extracellular matrix …

Idiopathic pulmonary fibrosis (IPF) is a progressive interstitial fibrotic disease that leads to
disability and death within 5 years of diagnosis. Pulmonary fibrosis is a disease with a …

Idiopathic pulmonary fibrosis (IPF) is characterized by devastating and progressive lung
parenchymal fibrosis, resulting in poor patient prognosis. An aberrant recapitulation of …

Idiopathic pulmonary fibrosis (IPF) is a lethal chronic lung disease characterized by aberrant
intercellular communication, extracellular matrix deposition, and destruction of functional …

Interstitial lung diseases (ILDs) are chronic irreversible pulmonary conditions with significant
morbidity and mortality. Diagnostic approaches to ILDs are complex and multifactorial …